The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
GMO Intl Developed Equity Allc III GIOTX
- NAV / 1-Day Return 17.37 / +0.70 %
- Total Assets 275.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.620%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 5.0 Mil
- Status Open
- TTM Yield 6.41%
- Turnover 9%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0
Morningstar’s Analysis GIOTX
Will GIOTX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 100.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
GMO International Equity IV | 70.09 | 177.1 Mil | — |
GMO International Opportunistic Val IV | 17.82 | 45.0 Mil | — |
GMO Emerging Markets ex-China VI | 8.13 | 20.5 Mil | — |
GMO-Usonian Japan Value Creation VI | 3.96 | 10.0 Mil | — |
State Street Instl Treasury MMkt Invsmt | 0.03 | 68,623 | Cash and Equivalents |
Asset Offset | 0.00 | 8,369 | — |
Other Liability | −0.03 | −72,878 | — |